Disconnect between FDA and doctors prescribing hydroxychloroquine

Published



A disconnect appears to have arisen between the Food and Drug Administration and a sizable number of physicians when it comes to prescribing hydroxychloroquine for COVID-19 patients.

The situation garnered extra attention last week when a group of physicians billing themselves as America’s Frontline Doctors insisted that the drug could treat COVID-19 in a high-profile press conference in Washington. Clips of the event went viral on social media before being blocked on some platforms as misinformation.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.